Objective: We examined gender differences in the clustering of risk factors, especially regarding the possible role of serum phosphate (S-P) in obese patients who participated in a 4 week education programme to reduce their excess risk of cardiovascular disease (CVD). Results: Signi®cantly higher body mass index (BMI) and concentrations of S-P and high density lipids (S-HDL) in serum were found in women (n 1272) than in men (n 993). In women, BMI was inversely correlated with S-P at the time of admission. Also in women (but not in men), changes in BMI and S-P over 1 or 1 1 2 y were inversely correlated. In men (but not in women), S-P level was inversely correlated with age, systolic blood pressure (SBP), diastolic blood pressure (DBP) and blood glucose at the time of admission. In women, S-P increased and DBP decreased, in addition to weight decrease over both 6 months and 1 1 2 y or 1 y. In women (but not in men), signi®cantly higher age, S-P, S-chol, S-TG, S-urate, SBP and DBP values were found with the highest vs the lowest decile of S-Ca. Conclusion: We conclude that higher S-P and S-Ca levels may contribute to the difference in metabolic disturbances occurring in obesity, seen in women vs men.
Introduction
Gender differences exist, and have frequently been described, in the prevalence of cardiovascular risk factors in different populations (Beregi et al, 1995; Wing & Jeffery, 1995; Srinivasan et al, 1991) . Degree and type of obesity may explain some of the gender differences in the metabolic syndrome. Obesity, glucose intolerance, accumulating abdominal fat, hyperinsulinaemia and hypertension are all known to be closely related in both genders (Kotchen et al, 1993; Pollare et al, 1990) . What has not hitherto been extensively studied is the role of phosphate in the clustering of risk factors (Ljunghall & Hedstrand, 1977; Linga Èrde & Trell, 1978) . The inverse relationship between serum phosphate (S-P) and either systolic blood pressure (SBP) or body mass index (BMI) is an interesting ®nding also for our understanding of the pathophysiology of the metabolic syndrome in men and women separately. The implication of serum calcium (S-Ca) in the differences in risk factors between genders must also be considered in this connection. Epidemiological data show that, in healthy men, S-P is inversely correlated with serum glucose (Sglu) levels (Ljunghall et al, 1979 ). The S-P level declines with age in men, but not in women (Sinton et al, 1986; Keating et al, 1969) . On the contrary, S-P increases in women after they have passed the age of 40 y (Keating et al, 1969) . Women have a higher S-HDL level than men, irrespective of body weight (Beregi et al, 1995; Haffner et al, 1995; Byrne et al, 1995; Davis et al, 1996) .
Experimental studies have also revealed that transport of S-glu and glucose metabolism are correlated with hypophosphataemia (Davis et al, 1979) . In clinical studies, hypophosphataemia was found to be related to reduced glucose tolerance, but also to disturbed myocardial function and hypertension (De Fronzo & Lang, 1980; Simonson & De Fronzo, 1982; O'Connor et al, 1977; Ognibene et al, 1994; Campese et al, 1984) .
We investigated the relationship of S-P and S-Ca with age, BMI, BP and maximum oxygen consumption (VO 2 -max) in women and men separately, in order to ascertain whether these electrolytes are equally related to cardiovascular risk factors in the metabolic syndrome in both genders.
Subjects and method

Patients
The material (calculated from registrations of body weight) comprised 2265 consecutive patients (1272 women and 993 men) admitted to a 4 week full-time patient education scheme during 1984 ± 1996, aimed at their mastering of hypertension, diabetes mellitus (DM), ischaemic heart disease or hyperlipidaemia. Most of the patients were obese. They were examined at registration (baseline data) regarding certain metabolic disturbances in the metabolic syndrome. Patients admitted between 1984 and 1987 (groups 1 ± 29, n 818) were invited to a follow-up after 6 months and again at 1 1 2 y. Patients admitted during the years 1987 ± 1996 (groups b 29, n 1805) were followed up after 1 y. The explanation for this strati®cation is that the time span to follow-up was changed from 6 months and 1 1 2 y to 1 y and that each group had therefore to be treated separately. No differences were found in BMI, S-P or serum triglycerides (S-TG) between the two populations. Values of S-glu, SBP, DBP and VO 2 -max were signi®cantly higher for patients admitted in 1984 ± 1987, than for those admitted in 1987 ± 1996. Patients remitted during the ®rst 4 y were suffering from the same diseases, though with a higher risk factor pro®le than patients treated thereafter.
Diet and physical activity
The patients were taught in one large group about healthrelated issues (eg cooking, meal planning, tobacco, ways of coping with stress and body image) and encouraged to take part in health-promoting exercise (eg walking, swimming). This theoretical and physical training occupied 53 h during the 4 week period. Furthermore, individual guidance was given by a physiotherapist, a dietitian, a nurse and a physician (varying numbers of hours during the period). Recipes and advice for a well-balanced diet were given to patients before they left the centre. The individual guidance was`problem-and individual-oriented' for each patient.
Metabolites and physical examination
Blood samples were drawn in the fasting state in the morning from all patients at the start of the programme and were analysed according to standardized routine procedures of the Department of Clinical Chemistry, University Hospital, Umea Ê, Sweden. The levels of S-P, S-Ca, S-glu, S-chol, S-HDL, S-TG and urate (S-urate) were determined by routine methods on Hitachi 717 multianalyser (Boehringer Mannheim Diagnostica, Mannheim, Germany). Serum phosphate was measured by a method based on the reduction of a phosphomolybdic acid complex with ammonium-iron (II)-sulphate and total calcium was determined colorimetrically after the formation of a complex with orto-cresolphtalein. SBP, DBP, VO 2 -max and BMI were registered.
Statistics
For analyses of baseline characteristics by metabolic disturbance, Student's t-test was used, with P-values based on two-sided tests of statistical signi®cance. Multivariate linear and log regression analyses were performed according to the textbook (Neter et al, 1983) . The SAS program pack was used.
Results
Body mass index (BMI) and serum phosphate (S-P) Obesity was common among the patients enrolled in the patient education scheme: (BMI 31 AE 6; n 2265). Some 77.5% of the patients had a BMI b 27 (77.3% of women and 77.7% of men), while 55.1% had a BMI b 30 (57.5% women, 52.0% men).
BMI, S-P and S-HDL values were signi®cantly higher in women than in men, whereas SBP, DBP, VO 2 -max, S-glu, S-TG and S-urate were signi®cantly lower (Table 1 ). In women (n 1272), the BMI was inversely correlated with S-P, S-TG, S-HDL, S-urate and VO 2 -max. In men, BMI was correlated with DBP, VO 2 -max, but inversely correlated with age. Bivariate correlations between S-P and risk factors in the metabolic syndrome are presented in Table 2 .
Both women and men, in the low decile of S-P, had higher BMI, SBP and lower S-Ca values than women and men in the highest S-P decile (Table 3) . Testing of the low ± high S-P hypothesis on a gender basis revealed that age distinguishes between men (53 AE 8 vs 48 AE 10 y) but not between women (49 AE 9 vs 50 AE 12 y) ( Table 3 ). Low S-P and high age in men were also seen in a comparison between low and high S-P levels within the normal S-P interval (0.82 ± 1.50 mmolal). For both genders, high BMI and low S-Ca levels were seen in the lower S-P levels, ie signi®cantly different from BMI and S-Ca at higher S-P levels, even within normal S-P intervals.
More men had a low S-P level (0.29 0.77; 157 vs 82) and more women had a high S-P level (1.27 2.88; 171 vs 76), compared with their counterparts. 
Serum calcium
Both women and men, in the low decile of S-Ca had lower S-P, serum cholesterol (S-chol), S-TG and S-urate values than women and men in the highest decile of S-Ca. Women with low S-Ca were signi®cantly younger than women with high S-Ca (Table 4) . Women with low S-Ca were younger and had higher S-P, S-HDL and lower S-glu, S-TG, S-urate, SBP and DBP than men with a low S-Ca value (Table 4) . High S-P, and S-HDL (but lower S-urate) values were found in women with high S-Ca vs men with high S-Ca.
Changes over time
Changes in the metabolic pro®le, from baseline to either 6 months and 1 1 2 y, or to 1 y was analyzed. Following health education prior to 1987, the follow-up at 6 months and 1 1 2 y revealed that men and women responded differently. The Table 3 Personal characteristics and the metabolic pro®les of women and men with low S-P (lowest decile) and high S-P (highest decile) levels
Women Men
Low S-P High S-P Low S-P High S-P (0.52 ± 0.82 mmolal) ( ! 1. 29 mmolal f signi®cance level P`0.001; between low and low S-P or high and high S-P between each gender. Hypophosphataemia in the metabolic syndrome L Ha Êglin et al reductions in S-chol, S-glu, S-TG and S-urate values were signi®cantly greater in men than in women. This was tested for in the multivariate analysis.
All risk factors changed signi®cantly, except for S-P (in women and men at 6 months and women at 1 1 2 and 1 y), SCa (in women and men at 1 y), S-glu (in women and men at 1 y and men at 6 months) and SBP (in men at 1 1 2 y). Weight reduction in all patients (n 2265) (over 6 months and 1 1 2 and 1 y) was correlated with changes in S-P (r 70.17; P`0.0001), S-glu (r 0.18; P`0.0001), S-TG (r 0.17; P`0.0001) and S-urate (r 0.18; P`0.0001).
Correlations between changes for the variables studied, over 1 or 1 1 2 y, are presented in Table 5 , but only if r is signi®cant on the P`0.05 level. The table contains data for both genders; the upper right section reports results calculated for women, while the lower left section contains data for men.
Multiple regression
Multiple regression analyses controlling for age, gender and BMI have been done. They con®rm the bivariate ®ndings (S-P and S-chol (P`0.02), S-P and BMI (P`0.001) and S-P and SBP (P`0.003)). Some other results from the multivariate analyses are presented in Table 6 .
Furthermore, correlations were found between S-glu and S-TG in both men and women after adjusting for BMI and age (P`0.0001). S-P was correlated with S-HDL after adjusting for age, BMI and VO 2 -max (P`0.04) but lost after adjusting for gender (P`0.94).
The inverse relationship between changes in S-P and Sglu persisted after adjusting for age, BMI, weight change, VO 2 -max and changed VO 2 -max for men (P`0.03), but not for women at 1 y or men at 1 1 2 y (P`0.08). The inverse relationship between changes in S-P and S-glu after correcting for the mentioned variables was also signi®cant for women after 1 1 2 y (P`0.022). There was also an inverse relationship between changes in S-P and BMI in women, when adjusted for age, BMI, VO 2 -max at baseline, and changes in VO 2 -max over 1 y (P`0.013).
In women, improved physical ®tness (VO 2 -max) was identi®ed as an independent predictor of S-P level. The greater improvements in S-chol, S-glu and S-TG in men than in women derives from the higher baseline values. The higher S-urate value at baseline and weight loss accounted for the changes in S-urate in both women and men.
Age was inversely correlated with S-P for men and positively for women after adjusting for BMI, VO 2 -max and S-HDL (P`0.001 and P`0.05 respectively).
Discussion
In the present study of the metabolic syndrome, gender differences in S-glu, S-TG and S-urate, SBP, DBP and physical performance (VO 2 -max) all seemed to be related to the S-P level. The higher levels of S-HDL and S-P and Hypophosphataemia in the metabolic syndrome L Ha Êglin et al lower S-urate and DBP levels in women could be a genuine gender-speci®c pro®le, and not merely differing according to lifestyle and dietary intake. Gender differences in phosphate metabolism have been reported in both experimental and clinical studies (Schwarz et al, 1985; Dominguez et al, 1976) . Women do have higher S-P levels, but the response to a low S-P intake is more severe than in men. Gender differences in urate metabolism, eg low levels in women vs men needs to be evaluated separately, before any conclusion about a causal relation to S-P levels can be presented. Another gender difference, of importance to discuss in this connection, is the increase in S-P with age in women, in contrast to the decrease with age in men seen in this study. This was described earlier in population-based studies (Sinton et al, 1986; Keating et al, 1969) . In the present study, only four of 21 patients with very low S-P levels were women. Increasing age is related to decreasing S-P after adjusting for BMI in men, but not in women. The signi®cantly differing S-P levels, low in men and high in women, warrant further investigation, as they might explain why women are protected from CVD during the ®fth decade of life, whereas men are not. Sinton et al, (1986) reported signi®cantly different S-P levels during the ®fth decade.
A role for S-P in the metabolic syndrome is indicated by the low ± high S-P hypothesis, with differences in SBP, BMI, age and VO 2 -max. Obesity and low S-P levels have been described earlier (Lind et al, 1993; Lindga Èrde & Trell, 1977) . The mechanism that causes hypophosphataemia in obesity, revealed by the inverse relationship between S-P and BMI also in the present study, can be attributed to an overconsumption of energy, eg a diet with a low nutrient density, or the result of phosphate depletion due to low protein intake. It is therefore important that both the total energy intake and the relative contributions of carbohydrates, protein and fat should be determined. Early studies described in detail the link between S-P and carbohydrate metabolism (Harrop & Benedict, 1924) . In obese individuals, an inability to metabolize glucose (possibly due to phosphate depletion), in addition to an increase in S-TG, could be the result of a dietary imbalance of protein, fat and carbohydrates.
The inverse correlation between S-P and S-glu at baseline and between changes in S-P and S-glu over 1 y in obese men, but not in women, is another expression of gender difference. An inverse correlation between changes in S-P and S-glu, stronger for men than for women, was also present after adjustment for some of the most important covariates. Moreover, in men (but not in women) the decrease in S-glu was associated with a decrease in S-TG. The greater improvement in risk factors for CVD in men vs women would appear to be due to higher baseline values. Higher S-TG and S-glu levels in men than in women have also been reported by others (eg Wing & Jeffery, 1995) .
Hyperglycaemia could be the result of a reduced capacity to metabolize glucose (Pollare et al, 1990) . Experimentally induced chronic hypophosphataemia restricts glucose uptake (Davis et al, 1979) . Metabolism and the level of S-P affects insulin secretion (Lindga Èrde & Trell, 1978) . In healthy humans, phosphate deprivation stimulates insulin secretion following intravenous administration of a glucose bolus (Marshall et al, 1978) .
Could the lower S-P level in obese men therefore be an expression of an increased CVD risk and a risk of NIDDM? Low S-P levels are associated with reduced cardiac output and also with arrhythmia (O'Connor et al, 1977) . The higher S-P levels in women as compared with men might then partly explain the diminished risk of CVD. A low S-P will give rise to hypertension among both men and women. A high S-Ca level may be involved in the pathogenesis of hypertension among women. Bone loss was correlated to hypertension in elderly women and the discussion was therefore concentrated on calcium depletion (Cappuccio et al, 1999) . A meta-analysis of published data led to the conclusion that, although there is an inverse relation between dietary calcium and hypertension, there is as yet insuf®cient evidence to recommend an increased intake for the treatment of high blood pressure (Cappuccio et al, 1995) . Thus, in women, in the present study a high S-Ca level (induced by a low S-P and demineralization) is implicated in the pathogenesis of hypertension, whereas in men the low S-P is a stronger indicator of high blood pressure.
Higher S-HDL levels in women, as well as an inverse correlation between S-HDL and S-TG, as compared with men, were found in the present patient population. S-P levels increase with weight loss for women, as does S-HDL for men. Thus, both parameters are inversely related to BMI and warrant further study of the metabolic syndrome.
Could the increase in S-P be a consequence of weight reduction, or is it an important contributory factor, for example by causing an increase in basal metabolic rate (BMR)? Obese (but not lean) women respond with an increased postprandial thermogenesis after infusion with magnesium-potassium-phosphate (Jaedig & Henningsen, 1991; Jaedig et al, 1994) . This effect might be due to increased synthesis of ATP following latent intracellular phosphate depletion in skeletal muscle.
Weight loss causes a decrease in S-TG in both genders but in women only in conjunction with a reduction in S-glu. Could the lower S-P level in men be a limiting factor for reduction of S-glu in connection with weight loss? Our ®ndings suggest such a possibility, which needs to be studied in other populations. The multivariate model did reveal that S-P could be of importance for both S-glu control and weight loss in the treatment of patients suffering from the metabolic syndrome. Hypophosphataemia might have a different etiology and effects on metabolism in women, as compared with men. To achieve an optimal protective and bene®cial effect concerning risk of cardiovascular disease, randomized controlled trials with hypophosphataemia prevention andaor treatment need to be performed in programme where weight-reduction is included. Our 4 week programme reduced risk factors for both genders, producing a signi®cantly greater decrease in Hypophosphataemia in the metabolic syndrome L Ha Êglin et al S-chol and S-TG in men than in women. Because of clustering of overrisks in this selected groups of patients a selection bias might have occurred.
Two important conclusions can still be drawn from our ®ndings. Higher S-HDL and S-P levels may both be protective markers in obese women, whereas in obese men, higher S-glu and SBP levels in addition to a lower S-P level, may be high-risk indicators. It is indicated that a high S-Ca level in women, but a low S-P in men, predicts hypertension, at least in the obese condition.
